Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
IMCD N.V. - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES
Ticker
Exchange
SIC #
Website
Latest Ticker
IMCDY
Over the counter
5122
www.imcdgroup.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for IMCD N.V.
IMCD (ENXTAM:IMCD) Stock May Still Offer A Discount As Medical Polymers Debut
- Nov 20th, 2026 10:14 am
IMCD receives SBTi validation of its science-based emissions reduction targets
- Nov 19th, 2026 12:00 am
Jefferies cuts 2 EU specialty chemical distributors as inflation tailwind fades
- Nov 11th, 2026 6:04 am
IMCD NV (IMCDY) (Q3 2026) Earnings Call Highlights: Organic Growth Accelerates to 10% as EBITA ...
- Nov 6th, 2026 10:15 pm
IMCD reports EBITA of EUR 425 million (+8%) in the first nine months of 2026
- Nov 4th, 2026 11:00 pm
IMCD (ENXTAM:IMCD) Stock Looks Cheap As Its 5 Year Slide Continues
- Oct 17th, 2026 8:15 pm
IMCD 2026 First Nine Months results webcast invitation
- Oct 15th, 2026 2:00 am
IMCD to acquire Willows Ingredients to strengthen its food & nutrition offering throughout Ireland and the UK
- Feb 20th, 2026 12:00 am
IMCD Full Year results 2025 webcast invitation
- Jan 21st, 2026 2:12 am
IMCD N.V.'s (AMS:IMCD) Intrinsic Value Is Potentially 99% Above Its Share Price
- Jan 1st, 2026 12:42 am
Floris Lagerwerf nominated future CFO of IMCD as of January 2027
- Dec 12th, 2025 12:00 am
Scroll